Sheller Spat Over FDA Risperdal Petition Denial Axed
By Shayna Posses ( October 7, 2016, 4:03 PM EDT) -- The Third Circuit affirmed Thursday that Sheller PC lacks standing to challenge the U.S. Food and Drug Administration's denial of a citizen petition requesting revocation of the agency's approval for Risperdal until its long-term safety can be shown and seeking to make a Johnson & Johnson unit publicize documents about the antipsychotic drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.